IRME · As filed with the SEC
IR-Med balance sheet, by quarter
The statement as IR-Med presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Interim Condensed Consolidated Balance Sheets (Unaudited) · USD thousands
| USD thousands | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets | ||||||||
| Cash and Cash Equivalents | 63 | 51 | 129 | 392 | 753 | 408 | 767 | 1,524 |
| Accounts Receivable | 27 | 30 | 76 | 51 | 36 | 55 | 81 | 83 |
| Total current assets | 90 | 81 | 205 | 443 | 789 | 463 | 848 | 1,607 |
| Non- current assets | ||||||||
| Long term restricted deposit | — | — | — | 11 | 11 | 11 | 11 | 11 |
| Long-Term Investments | — | — | 11 | — | — | — | — | — |
| Restricted Cash, Non-Current | 11 | 11 | — | — | — | — | — | — |
| Operating Lease Right-of-Use Asset | 45 | — | — | 40 | 45 | 58 | 84 | 100 |
| Property, Plant and Equipment | 29 | 32 | 35 | 39 | 42 | 47 | 56 | 55 |
| Total non-current assets | 85 | 43 | 46 | 90 | 98 | 116 | 151 | 166 |
| Total assets | 175 | 124 | 251 | 533 | 887 | 579 | 999 | 1,773 |
| Liabilities and Stockholders’ equity | ||||||||
| Current liabilities | ||||||||
| Accounts Payable | 393 | 428 | 388 | 376 | 367 | 505 | 473 | 407 |
| Deferred grant income | 173 | — | — | — | — | — | — | — |
| Short-Term Debt | 176 | 158 | 157 | — | — | — | — | 152 |
| Short-Term Debt | 32 | 31 | — | — | — | — | — | — |
| Total Current Liabilities | 774 | 617 | 545 | — | — | — | 473 | 559 |
| Non-current liabilities | ||||||||
| Stockholders’ loans | — | — | — | 155 | 157 | 160 | 161 | — |
| Operating Lease Liability, Non-Current | 26 | — | — | — | — | — | — | 2 |
| Total Non-Current Liabilities | 26 | — | — | — | — | — | 161 | 2 |
| Total liabilities | 800 | 617 | 545 | 531 | 524 | 665 | 634 | 561 |
| Stockholders’ deficit | ||||||||
| Total Stockholders' Equity | 77 | 72 | 70 | 70 | 70 | 69 | 69 | 69 |
| Additional Paid-In Capital | 17,510 | 16,946 | 16,374 | 16,392 | 16,155 | 15,341 | 15,135 | 14,711 |
| Retained Earnings | (18,212) | (17,511) | (16,738) | (16,460) | (15,862) | (15,496) | (14,839) | (13,568) |
| Total Stockholders’ deficit | (625) | (493) | (294) | 2 | 363 | (86) | 365 | 1,212 |
| Total liabilities and stockholders’ deficit | 175 | 124 | 251 | 533 | 887 | 579 | 999 | 1,773 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.